Autoimmune Disease Diagnostics Market Share, Size, Growth By 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Autoimmune Disease Diagnostics Market Size Analysis

Global Autoimmune Disease Diagnostics Market Introduction
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Disease
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Psoriasis
    1. Psoriasis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  6. Ankylosing spondylitis
    1. Ankylosing spondylitis By Value
  7. Other Systemic Autoimmune Diseases
    1. Other Systemic Autoimmune Diseases By Value
3. Localized Autoimmune Disease
  1. By Value
  2. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Thyroid
    1. Thyroid By Value
  5. Multiple sclerosis
    1. Multiple sclerosis By Value
  6. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  7. Idiopathic thrombocytopenic purpura
    1. Idiopathic thrombocytopenic purpura By Value
  8. Other Localized Autoimmune Diseases
    1. Other Localized Autoimmune Diseases By Value
By Diagnosis
1. Introduction
  1. Diagnosis By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. Complete Blood Count (CBC)
  1. By Value
5. C-reactive Protein (CRP)
  1. By Value
6. Urinalysis
  1. By Value
7. Comprehensive Metabolic Panel
  1. By Value
8. Erythrocyte Sedimentation Rate (ESR)
  1. By Value
9. Other Tests
  1. By Value

North America Market Analysis

Introduction
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Disease
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Psoriasis
    1. Psoriasis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  6. Ankylosing spondylitis
    1. Ankylosing spondylitis By Value
  7. Other Systemic Autoimmune Diseases
    1. Other Systemic Autoimmune Diseases By Value
3. Localized Autoimmune Disease
  1. By Value
  2. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Thyroid
    1. Thyroid By Value
  5. Multiple sclerosis
    1. Multiple sclerosis By Value
  6. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  7. Idiopathic thrombocytopenic purpura
    1. Idiopathic thrombocytopenic purpura By Value
  8. Other Localized Autoimmune Diseases
    1. Other Localized Autoimmune Diseases By Value
By Diagnosis
1. Introduction
  1. Diagnosis By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. Complete Blood Count (CBC)
  1. By Value
5. C-reactive Protein (CRP)
  1. By Value
6. Urinalysis
  1. By Value
7. Comprehensive Metabolic Panel
  1. By Value
8. Erythrocyte Sedimentation Rate (ESR)
  1. By Value
9. Other Tests
  1. By Value
U.S.
1. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Disease
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Psoriasis
      1. Psoriasis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    6. Ankylosing spondylitis
      1. Ankylosing spondylitis By Value
    7. Other Systemic Autoimmune Diseases
      1. Other Systemic Autoimmune Diseases By Value
  3. Localized Autoimmune Disease
    1. By Value
    2. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Thyroid
      1. Thyroid By Value
    5. Multiple sclerosis
      1. Multiple sclerosis By Value
    6. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    7. Idiopathic thrombocytopenic purpura
      1. Idiopathic thrombocytopenic purpura By Value
    8. Other Localized Autoimmune Diseases
      1. Other Localized Autoimmune Diseases By Value
2. By Diagnosis
  1. Introduction
    1. Diagnosis By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. Complete Blood Count (CBC)
    1. By Value
  5. C-reactive Protein (CRP)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Comprehensive Metabolic Panel
    1. By Value
  8. Erythrocyte Sedimentation Rate (ESR)
    1. By Value
  9. Other Tests
    1. By Value
Canada

Europe Market Analysis

Introduction
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Disease
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Psoriasis
    1. Psoriasis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  6. Ankylosing spondylitis
    1. Ankylosing spondylitis By Value
  7. Other Systemic Autoimmune Diseases
    1. Other Systemic Autoimmune Diseases By Value
3. Localized Autoimmune Disease
  1. By Value
  2. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Thyroid
    1. Thyroid By Value
  5. Multiple sclerosis
    1. Multiple sclerosis By Value
  6. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  7. Idiopathic thrombocytopenic purpura
    1. Idiopathic thrombocytopenic purpura By Value
  8. Other Localized Autoimmune Diseases
    1. Other Localized Autoimmune Diseases By Value
By Diagnosis
1. Introduction
  1. Diagnosis By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. Complete Blood Count (CBC)
  1. By Value
5. C-reactive Protein (CRP)
  1. By Value
6. Urinalysis
  1. By Value
7. Comprehensive Metabolic Panel
  1. By Value
8. Erythrocyte Sedimentation Rate (ESR)
  1. By Value
9. Other Tests
  1. By Value
U.K.
1. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Disease
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Psoriasis
      1. Psoriasis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    6. Ankylosing spondylitis
      1. Ankylosing spondylitis By Value
    7. Other Systemic Autoimmune Diseases
      1. Other Systemic Autoimmune Diseases By Value
  3. Localized Autoimmune Disease
    1. By Value
    2. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Thyroid
      1. Thyroid By Value
    5. Multiple sclerosis
      1. Multiple sclerosis By Value
    6. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    7. Idiopathic thrombocytopenic purpura
      1. Idiopathic thrombocytopenic purpura By Value
    8. Other Localized Autoimmune Diseases
      1. Other Localized Autoimmune Diseases By Value
2. By Diagnosis
  1. Introduction
    1. Diagnosis By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. Complete Blood Count (CBC)
    1. By Value
  5. C-reactive Protein (CRP)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Comprehensive Metabolic Panel
    1. By Value
  8. Erythrocyte Sedimentation Rate (ESR)
    1. By Value
  9. Other Tests
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Disease
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Psoriasis
    1. Psoriasis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  6. Ankylosing spondylitis
    1. Ankylosing spondylitis By Value
  7. Other Systemic Autoimmune Diseases
    1. Other Systemic Autoimmune Diseases By Value
3. Localized Autoimmune Disease
  1. By Value
  2. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Thyroid
    1. Thyroid By Value
  5. Multiple sclerosis
    1. Multiple sclerosis By Value
  6. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  7. Idiopathic thrombocytopenic purpura
    1. Idiopathic thrombocytopenic purpura By Value
  8. Other Localized Autoimmune Diseases
    1. Other Localized Autoimmune Diseases By Value
By Diagnosis
1. Introduction
  1. Diagnosis By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. Complete Blood Count (CBC)
  1. By Value
5. C-reactive Protein (CRP)
  1. By Value
6. Urinalysis
  1. By Value
7. Comprehensive Metabolic Panel
  1. By Value
8. Erythrocyte Sedimentation Rate (ESR)
  1. By Value
9. Other Tests
  1. By Value
China
1. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Disease
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Psoriasis
      1. Psoriasis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    6. Ankylosing spondylitis
      1. Ankylosing spondylitis By Value
    7. Other Systemic Autoimmune Diseases
      1. Other Systemic Autoimmune Diseases By Value
  3. Localized Autoimmune Disease
    1. By Value
    2. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Thyroid
      1. Thyroid By Value
    5. Multiple sclerosis
      1. Multiple sclerosis By Value
    6. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    7. Idiopathic thrombocytopenic purpura
      1. Idiopathic thrombocytopenic purpura By Value
    8. Other Localized Autoimmune Diseases
      1. Other Localized Autoimmune Diseases By Value
2. By Diagnosis
  1. Introduction
    1. Diagnosis By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. Complete Blood Count (CBC)
    1. By Value
  5. C-reactive Protein (CRP)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Comprehensive Metabolic Panel
    1. By Value
  8. Erythrocyte Sedimentation Rate (ESR)
    1. By Value
  9. Other Tests
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Disease
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Psoriasis
    1. Psoriasis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  6. Ankylosing spondylitis
    1. Ankylosing spondylitis By Value
  7. Other Systemic Autoimmune Diseases
    1. Other Systemic Autoimmune Diseases By Value
3. Localized Autoimmune Disease
  1. By Value
  2. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Thyroid
    1. Thyroid By Value
  5. Multiple sclerosis
    1. Multiple sclerosis By Value
  6. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  7. Idiopathic thrombocytopenic purpura
    1. Idiopathic thrombocytopenic purpura By Value
  8. Other Localized Autoimmune Diseases
    1. Other Localized Autoimmune Diseases By Value
By Diagnosis
1. Introduction
  1. Diagnosis By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. Complete Blood Count (CBC)
  1. By Value
5. C-reactive Protein (CRP)
  1. By Value
6. Urinalysis
  1. By Value
7. Comprehensive Metabolic Panel
  1. By Value
8. Erythrocyte Sedimentation Rate (ESR)
  1. By Value
9. Other Tests
  1. By Value
UAE
1. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Disease
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Psoriasis
      1. Psoriasis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    6. Ankylosing spondylitis
      1. Ankylosing spondylitis By Value
    7. Other Systemic Autoimmune Diseases
      1. Other Systemic Autoimmune Diseases By Value
  3. Localized Autoimmune Disease
    1. By Value
    2. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Thyroid
      1. Thyroid By Value
    5. Multiple sclerosis
      1. Multiple sclerosis By Value
    6. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    7. Idiopathic thrombocytopenic purpura
      1. Idiopathic thrombocytopenic purpura By Value
    8. Other Localized Autoimmune Diseases
      1. Other Localized Autoimmune Diseases By Value
2. By Diagnosis
  1. Introduction
    1. Diagnosis By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. Complete Blood Count (CBC)
    1. By Value
  5. C-reactive Protein (CRP)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Comprehensive Metabolic Panel
    1. By Value
  8. Erythrocyte Sedimentation Rate (ESR)
    1. By Value
  9. Other Tests
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Disease Type
1. Introduction
  1. Disease Type By Value
2. Systemic Autoimmune Disease
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Psoriasis
    1. Psoriasis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  6. Ankylosing spondylitis
    1. Ankylosing spondylitis By Value
  7. Other Systemic Autoimmune Diseases
    1. Other Systemic Autoimmune Diseases By Value
3. Localized Autoimmune Disease
  1. By Value
  2. Inflammatory Bowel Disease
    1. Inflammatory Bowel Disease By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Thyroid
    1. Thyroid By Value
  5. Multiple sclerosis
    1. Multiple sclerosis By Value
  6. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  7. Idiopathic thrombocytopenic purpura
    1. Idiopathic thrombocytopenic purpura By Value
  8. Other Localized Autoimmune Diseases
    1. Other Localized Autoimmune Diseases By Value
By Diagnosis
1. Introduction
  1. Diagnosis By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. Complete Blood Count (CBC)
  1. By Value
5. C-reactive Protein (CRP)
  1. By Value
6. Urinalysis
  1. By Value
7. Comprehensive Metabolic Panel
  1. By Value
8. Erythrocyte Sedimentation Rate (ESR)
  1. By Value
9. Other Tests
  1. By Value
Brazil
1. By Disease Type
  1. Introduction
    1. Disease Type By Value
  2. Systemic Autoimmune Disease
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Psoriasis
      1. Psoriasis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    6. Ankylosing spondylitis
      1. Ankylosing spondylitis By Value
    7. Other Systemic Autoimmune Diseases
      1. Other Systemic Autoimmune Diseases By Value
  3. Localized Autoimmune Disease
    1. By Value
    2. Inflammatory Bowel Disease
      1. Inflammatory Bowel Disease By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Thyroid
      1. Thyroid By Value
    5. Multiple sclerosis
      1. Multiple sclerosis By Value
    6. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    7. Idiopathic thrombocytopenic purpura
      1. Idiopathic thrombocytopenic purpura By Value
    8. Other Localized Autoimmune Diseases
      1. Other Localized Autoimmune Diseases By Value
2. By Diagnosis
  1. Introduction
    1. Diagnosis By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. Complete Blood Count (CBC)
    1. By Value
  5. C-reactive Protein (CRP)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Comprehensive Metabolic Panel
    1. By Value
  8. Erythrocyte Sedimentation Rate (ESR)
    1. By Value
  9. Other Tests
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Autoimmune Disease Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott Laboratories
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Biomerieux SA
Bio-rad Laboratories Inc
PerkinElmer Inc. (Euroimmun AG)
Hoffmann-la Roche Ltd
Werfen Company (Inova Diagnostics Inc.)
Myriad Genetics Inc
Siemens Healthineers Inc
Thermo Fisher Scientific Inc
Trinity Biotech PLC

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment